Your session is about to expire
← Back to Search
Procedure
Femoral Articular Branch Block for Post-Hip Arthroscopy Pain Management
N/A
Recruiting
Led By Richard Brull, MD
Research Sponsored by Women's College Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up until one month following nerve block
Awards & highlights
Study Summary
This trial is testing whether a new regional anesthesia technique, the femoral articular branch block, can reduce pain and improve recovery for patients having hip arthroscopy.
Who is the study for?
This trial is for adults aged 18-60 with a BMI under 35 and in good health (ASA I-III). It's not for those with nerve issues, infections at the injection site, bleeding disorders, chronic pain conditions, high opioid use, allergies to local anesthesia or certain pain meds, significant psychiatric conditions that could affect assessments, pregnant individuals or anyone unable to consent.Check my eligibility
What is being tested?
The study tests if a regional anesthesia technique called Femoral Articular Branch Block (FAB) can reduce pain and opioid use after hip arthroscopy compared to a placebo. Participants are randomly assigned to receive either FAB or a fake block in this double-blind study.See study design
What are the potential side effects?
While specific side effects aren't listed here, typical risks of regional blocks may include discomfort at the injection site, infection risk from the needle entry point and potential nerve damage. The placebo group should experience minimal side effects.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one month after surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month after surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Quality of Life scores
Secondary outcome measures
Analgesic Consumption
Demographic Data
Incidence of opioid-related side effects
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Femoral Articular Branch BlockExperimental Treatment1 Intervention
Patients will receive an ultrasound-guided femoral articular branch block with an injection of 20ml of ropivicaine 0.5%
Group II: Placebo BlockPlacebo Group1 Intervention
Patients will receive an ultrasound simulation of the location of a femoral articular branch block , this is to maintain blinding. A subcutaneous injection of 1ml of normal sterile saline will be administered
Find a Location
Who is running the clinical trial?
Women's College HospitalLead Sponsor
100 Previous Clinical Trials
38,709 Total Patients Enrolled
2 Trials studying Regional Anesthesia
155 Patients Enrolled for Regional Anesthesia
Richard Brull, MDPrincipal InvestigatorWomen's College Hospital, University of Toronto
15 Previous Clinical Trials
1,389 Total Patients Enrolled
1 Trials studying Regional Anesthesia
95 Patients Enrolled for Regional Anesthesia
Daniel Whelan, MDPrincipal InvestigatorWomen's College Hospital, University of Toronto
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Femoral Articular Branch Block
- Group 2: Placebo Block
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Surgical and Radiologic AnatomyJournal
The Sensory Innervation of the Hip Joint - an Anatomical StudyShare this study with friends
Copy Link
Messenger